Table_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.xlsx by Kanwal M. Hameed (18386853)

“…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”

qRT-PCR indicates <i>runx1</i>, <i>cmyb</i>, and <i>cd41</i> expression is lower in PCP treated embryos. by Aleeza Namit (12295157)

DataSheet_1_Dual targeting of glutamine and serine metabolism in acute myeloid leukemia.pdf by Kanwal M. Hameed (18386853)

“…<p>Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy characterized by disrupted blood cell production and function. …”

PD-1 deficiency does obviously not change B cell and CD11b⁺ myeloid cell IHC staining in livers following <i>S</i>. <i>japonicum</i> infection. by Liaoxun Lu (179293)

Supplementary Material for: Regulation of miR-126 and miR-122 Expression and Response of Imatinib Treatment on Its Expression in Chronic Myeloid Leukemia Patients by AliBeg M.M. (11278041)

“…The expression of miR-126 was not conclusive when compared in different clinical stages of the CML disease as it showed a decreased expression in patients with accelerated phase compared to chronic phase (mean fold change = 0.03 and 0.27, respectively), but patients with chronic phase and blastic phase had comparable expression (mean fold change = 0.27 and 0.24, respectively). …”

<i>Drosophila CG8501</i>, an orthologous gene of human <i>CD59</i>. by Sang-Ho Yoon (10123698)

Myeloid precursor cell line U937 differentiation affected by PDAC PortalBMC conditioned media. by Juan Pablo Arnoletti (12275290)

“…Conditioned media from untreated cultures (<b>zero</b>) and humanized anti-CSF1R, humanized anti-IL-8 or anti-CSF1R+anti-IL-8 treated cultures did not statistically decrease the myeloid differentiation of U937 cells to Macrophage, Dendritic Cell, MDSC, and M-FB phenotypes. …”

<i>Drosophila CG8501</i>, an orthologous gene of human <i>CD59</i>. by Sang-Ho Yoon (10123698)

Image3_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”

Image1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”

Image2_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.pdf by Xingrong Lai (12526789)

“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”

Multimodal treatment regimen restores decreased immune cell activation and proliferation in descending colon tissue. by Rachele M. Bochart (10777099)

CSF1R and IL-8 mediated signaling affect PDAC portal blood CTC proliferation, cluster formation, and apoptosis. by Juan Pablo Arnoletti (12275290)

RNA expression of myeloid growth factor signaling ligands and their receptors found in PDAC CTC and M-FB after PortalBMC <i>ex vivo</i> culture. by Juan Pablo Arnoletti (12275290)

Inhibition of CSF1R, IL-8, and IL-34 reduces T cell anergy in PortalBMC <i>ex vivo</i> cultures. by Juan Pablo Arnoletti (12275290)

Figure 4 from FLT3/CD99 Bispecific Antibody–Based Nanoparticles for Acute Myeloid Leukemia by Atham Ali (19345980)

Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

DataSheet1_Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells.xlsx by Xingrong Lai (12526789)

“…<p>Acute myeloid leukemia (AML) is one of the malignant hematological cancers with high mortality. …”

DataSheet_1_Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia.pdf by Carlos C. Smith-Díaz (11312490)

“…We found that the addition of ascorbate had a minimal effect on Prima-1^Met–induced cytotoxicity, with small increases or decreases in cytotoxicity being observed depending on the timing of treatment. …”

Nilotinib treatment of Mtb-infected mice activates lysosome functions of lung myeloid subsets and reduces lung bacterial burdens. by Weihao Zheng (767955)

“…(B-C) Nilotinib treatment of mice (B) decreases overall Mtb lung bacterial burdens and (C) reduces infected lung myeloid cells in treated mice (28 dpi). …”